Articles

Poll

Podcasts

Slideshows

Videos

Carotid ultrasound data reveal early arterial injury even at earlier CKM stages, says Donald Lloyd-Jones, MD, MS

4 Out of 5 Young Adults Show Early Cardiovascular-Kidney-Metabolic Risk

Samir Parikh, MD, on the B-cell pathway in IgA nephropathy, biomarker gaps, treatment sequencing, and the case for earlier detection.

Understanding the B-Cell Pathway in IgA Nephropathy, With Samir Parikh, MD

This week's highlight includes phase 3 trial results across dermatology, cardiology, and pulmonology, and a major conference preview.

The HCPFive: Top News for Healthcare Providers from the Week of 08/09

Mohamad Hussain, MD, PhD, discusses Phase 3 findings on Humacyte's bioengineered vessel and its potential role in vascular access for women on dialysis.

Bioengineered Vessel Increases Catheter-Free Time in Women on Dialysis

Dana Rizk, MD, joins hosts Brendon Neuen and Shikha Wadhwani to unpack 2-year VISIONARY data showing sibeprenlimab stabilizes eGFR in IgAN.

Kidney Compass: VISIONARY 2-Year eGFR Data in IgA Nephropathy

Brad Rovin, MD, discusses persistent gaps in IgA nephropathy diagnosis and treatment, from RAS inhibition limits to the promise of B-cell-targeted therapies.

What's Still Missing in IgA Nephropathy Care, With Brad Rovin, MD

Brad Rovin, MD, discusses gaps in IgA nephropathy care, biopsy's expanding role, and how new B cell therapies are reshaping treatment.

Closing Gaps in IgA Nephropathy Diagnosis and Treatment, With Brad Rovin, MD

Matthew Breeggemann, MD, of UCSF discusses genetic testing, risk stratification, and the future of personalized CKD management in 2026.

Rethinking CKD: AKI's Long-Term Impact and the Push for Earlier Intervention

Stay updated with the latest healthcare breakthroughs, including phase 3 sibeprenlimab data in IgAN and the FDA approval of oveporexton for narcolepsy.

The HCPFive: Top News for Healthcare Providers from the Week of 08/02

Sibeprenlimab (Voyxact) achieves KDIGO goal, stabilizing eGFR decline in IgA nephropathy at 2-year Phase 3 VISIONARY readout. 

Sibeprenlimab (Voyxact) Stabilizes Kidney Function in IgAN

C3 Glomerulopathy

The HCPLive C3 glomerulopathy page is a resource for medical news and expert insights on C3G. This page features expert-led coverage, articles, videos and research on the therapies and development of treatments in C3G, and more.

IgA Nephropathy

The HCPLive Berger disease page is a resource for medical news and expert insights on IgA nephropathy. This page features expert-led coverage, articles, videos and research on the therapies and development of treatments in Berger disease, and more.

Focal Segmental Glomerulosclerosis

The HCPLive focal segmental glomerulosclerosis page is a resource for medical news and expert insights on FSGS. This page features expert-led coverage, articles, videos and research on the therapies and development of treatments in FSGS, and more. 

Chronic Kidney Disease

The HCPLive nephrology page is a resource for medical news and expert insights on kidney disease. This page features expert-led coverage, articles, videos and research on the therapies and development of treatments in nephrology, and more.

Nephrology